PNPLA2 and Parkinson disease: To further confirm the roles of LDs and mitochondria in CIH-enhanced PD susceptibility, we employed compound 86 (an ATGL activator) to enhance LD catabolism and mdivi-1 (Drp1 phosphorylation inhibitor) to suppress mitochondrial fission, respectively (Figure 5A) 22,23.